| Name | BMS-1166 |
|---|---|
| Synonyms |
BMS-1166 ,S8859
BMS-1166 (Synonyms: PD-1/PD-L1-IN1) BMS-1166, 10 mM in DMSO PD-1/PD-L1-IN1 BMS-1166 D-Proline, 1-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]phenyl]methyl]-4-hydroxy-, (4R) PD-1/PD-L1-IN1 Inhibitor,BMS1166,BMS 1166,activation,immune,cell,interaction,BMS-1166,dimerization,checkpoint,inhibit (2R,4R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypyrrolidine-2-cboxylic acid BMS 1166Q: What is BMS 1166 Q: What is the CAS Number of BMS BMS-1166 (PD-1/PD-L1-IN1) |
| Description | BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor with an IC50 of 1.4 nM. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.4 nM (PD-1/PD-L1 interaction)[1]. |
| In Vitro | BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 1.4 nM in a homogenous time-resolved fluorescence binding assay[1]. BMS-1166 antagonizes the inhibitory effect of PD-1/PD-L1 immune checkpoint on T cell activation. BMS-1166 dose dependently abolishes the inhibition of ECs stimulation by sPD-L1[2]. |
| References |
| Molecular Formula | C36H33ClN2O7 |
|---|---|
| Molecular Weight | 641.11 |
| Storage condition | 2-8℃ |